Reviews: Zotarolimus stent shows efficacy in diabetes patients

04/22/2013 | Healio

Resolute Integrity's zotarolimus-eluting stent helped reduce target vessel failure rate and proved safe and effective in patients with diabetes, an analysis revealed. Another review showed insulin-treated diabetes patients had higher target lesion failure rates than non–insulin-treated diabetes patients. The results appear in JACC: Cardiovascular Interventions.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC